- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Points to Consider in Continuous Manufacturing of Biotechnological Products
-
- OKUDAIRA Shinichi
- Pharmaceuticals and Medical Devices Agency
-
- SAKURAI Kyoko
- Pharmaceuticals and Medical Devices Agency
-
- TAKEDA Hiroshi
- Pharmaceuticals and Medical Devices Agency
-
- MATSUDA Yoshihiro
- Pharmaceuticals and Medical Devices Agency
-
- TAKARADA Tetsuhito
- Pharmaceuticals and Medical Devices Agency
-
- KONDO Kohei
- Pharmaceuticals and Medical Devices Agency
-
- TAKAHASHI Masabumi
- Pharmaceuticals and Medical Devices Agency
-
- ISHII Ryusei
- Pharmaceuticals and Medical Devices Agency
-
- UCHIDA Kazuhisa
- Graduate School of Science, Technology and Innovation, Kobe University
-
- EUI LEE In
- Graduate School of Science, Technology and Innovation, Kobe University
-
- WADA Kazuyo
- Biologics Center for Research and Training
-
- KOBAYASHI Yuki
- Kyowa Kirin Co., Ltd.
-
- SHIMIZU Rie
- Otsuka Pharmaceutical Co., Ltd.
-
- KATO Yasubumi
- JGC JAPAN CORPORATION
-
- KURASHIMA Hideki
- Nihon Pall Ltd.
-
- HATAYAMA Katsuhiro
- 3M Japan Innovation Limited
-
- OHDA Toyoo
- Mitsubishi Tanabe Pharma Corporation
-
- TORIKAI Yusuke
- Chugai Pharma Manufacturing Co., Ltd.
-
- KARIYA Kinya
- Nitten Pharmaceutical Co., Ltd.
-
- TSUKAMOTO Jiro
- MicroBiopharm Japan Co., Ltd.
-
- OKURA Hiroya
- Astellas Pharma Inc.
-
- WATANABE Naoto
- Asahi Kasei Medical Co., Ltd.
-
- MURAI Kastushi
- Japan Blood Products Organization
-
- HARIGANEYA Naohito
- Nihon Pall Ltd.
-
- HIRASAWA Ryutaro
- Pharmaceuticals and Medical Devices Agency
-
- HONGO Tomoko
- Asahi Kasei Medical Co., Ltd.
-
- OYAMA Kazunobu
- Daiichi Sankyo Co., Ltd.
-
- TOKIEDA Yoshiyuki
- KM Biologics Co., Ltd.
-
- OTA Yasumasa
- Meiji Seika Pharma Co., Ltd.
-
- SHIBATA Mizuyo
- Novartis Pharma K.K.
-
- SHINONAGA Hideki
- Taisho Pharmaceutical Co., Ltd.
-
- SHIBA Yoichiro
- Daiichi Sankyo Co., Ltd.
-
- SHIMIZU Yoshiaki
- Kissei Pharmaceutical Co., Ltd.
-
- YOSHINO Takeshi
- Chugai Pharma Manufacturing Co., Ltd.
-
- HORIUCHI Takayuki
- Manufacturing Technology Association of Biologics Chitose Laboratory Corp.
-
- ISHIKAWA Yoshimitsu
- Manufacturing Technology Association of Biologics Life Science Research Laboratory, TOSOH Corporation
-
- OE Seigo
- Manufacturing Technology Association of Biologics Life Science Research Laboratory, TOSOH Corporation
-
- KAWASAKI Tadayoshi
- Manufacturing Technology Association of Biologics
-
- SHIBATA Hiroko
- National Institute of Health Sciences
-
- HYUGA Masashi
- National Institute of Health Sciences
-
- HONDA Shinya
- Manufacturing Technology Association of Biologics National Institute of Advanced Industrial Science and Technology
-
- YAMAMOTO Shuichi
- Manufacturing Technology Association of Biologics Biomedical Engineering Center, Yamaguchi University
-
- MURAKAMI Sei
- Manufacturing Technology Association of Biologics Hitachi, Ltd.
-
- OMASA Takeshi
- Manufacturing Technology Association of Biologics Graduate School of Engineering, Osaka University
-
- ISHII-WATABE Akiko
- National Institute of Health Sciences
Bibliographic Information
- Other Title
-
- バイオ医薬品の連続生産に関するPoints to Consider
Search this article
Description
<p>Continuous manufacturing is a manufacturing method in which raw materials are entered continuously in the manufacturing process throughout the duration of the process, and products are produced continuously through the manufacturing. Continuous manufacturing is applicable in various ways: Where all the stages of manufacturing process are continuous, from charging raw materials to discharging final products; and where only certain stages of the manufacturing process are continuous. With its continuous process operation, continuous manufacturing will be expected to maintain production efficiency irrespective of the equipment scale. By adjusting such as the continuous operating time in the process, continuous manufacturing can cater for a wide range of batch size. Therefore the same manufacturing equipment can be used from the developmental phase to the commercial phase. Continuous manufacturing is considered an efficient manufacturing technology, and considered to be one of major manufacturing technology in pharmaceutical production. Number of guidelines, however, published by regulatory agencies regarding continuous manufacturing is limited. There is no guideline by regulatory agencies specific to continuous manufacturing of biotechnological products. In this paper, we described points to consider when designing control strategy of continuous manufacturing of biotechnological products.</p>
Journal
-
- PDA Journal of GMP and Validation in Japan
-
PDA Journal of GMP and Validation in Japan 23 (1), 13-22, 2021
Parenteral Drug Association Japan Chapter
- Tweet
Details 詳細情報について
-
- CRID
- 1390007060643624576
-
- NII Article ID
- 130008059002
-
- ISSN
- 18811728
- 13444891
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- CiNii Articles
- KAKEN
-
- Abstract License Flag
- Disallowed